Dutch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Steroids in Treatment of Viral Encephalitis

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
De link wordt op het klembord opgeslagen
ToestandNog niet aan het werven
Sponsors
Assiut University

Sleutelwoorden

Abstract

acute viral encephalitis is used to describe restricted CNS involvement (namely, involvement of the brain, sparing the meninges)

Omschrijving

Viral encephalitis is a medical emergency The spectrum of brain involvement and the prognosis are dependent mainly on the specific pathogen and the immunological state of the host.

Although specific therapy is limited to only several viral agents, correct immediate diagnosis and introduction of symptomatic and specific therapy has a dramatic influence upon survival and reduces the extent of permanent brain injury in survivors Epidemiologic studies estimate the incidence of viral encephalitis at 3.5 to 7.4 per 100,000 persons per year. Overall, viruses are the most common cause of encephalitis.

The Centers for Disease Control and Prevention (CDC) estimates an annual incidence of approximately 20,000 new cases of encephalitis in the United States; most are mild in nature. The mortality depends largely on the etiologic agent of the encephalitis.

Herpes simplex virus (HSV) encephalitis (HSVE) is the most common cause of sporadic encephalitis in humans. More than 90% of HSVE cases are attributable to HSV type-1 (HSV-1). Approximately 5% of them are caused by HSV type-2 HSVE is a severe disease, often leading to high morbidity (40%) and mortality (up to 15% in treated cases and 70% in untreated cases) Patients with encephalitis have an altered mental status ranging from subtle deficits to complete unresponsiveness. The typical clinical presentation includes a rapid onset of fever and impaired consciousness, often accompanied by focal neurologic signs and seizures.

The current treatment of choice is the viral replication inhibitor acyclovir. Although highly effective in reducing mortality, it only results in complete recovery in one-half of patients . Steroid therapy as an adjunctive therapy in HSVE has good anti inflammatory effect. Steroid therapy has both anti inflammatory and immunosuppressive property.

The diagnosis of viral encephalitis is suspected in the context of a febrile disease accompanied by headache, altered level of consciousness, and symptoms and signs of cerebral dysfunction. These may consist of abnormalities that can be categorized into four: cognitive dysfunction (acute memory disturbances), behavioural changes (disorientation, hallucinations, psychosis, personality changes, agitation), focal neurological abnormalities (such as anosmia, dysphasia, hemiparesis, hemianopia etc.) and seizures. After the diagnosis is suspected, the approach should consist of obtaining a meticulous history and a careful general and neurological examination.

Datums

Laatst geverifieerd: 12/31/2019
Eerste ingediend: 09/23/2019
Geschatte inschrijving ingediend: 09/23/2019
Eerst geplaatst: 09/24/2019
Laatste update ingediend: 01/27/2020
Laatste update geplaatst: 01/28/2020
Werkelijke startdatum van het onderzoek: 03/29/2020
Geschatte primaire voltooiingsdatum: 03/29/2021
Geschatte voltooiingsdatum van het onderzoek: 08/29/2021

Conditie of ziekte

Encephalitis, Viral

Interventie / behandeling

Drug: Patients will receive steroid pulse therapy

Drug: Patients will receive low dose steroids

Fase

Fase 4

Armgroepen

ArmInterventie / behandeling
Experimental: Patients will receive steroid pulse therapy
Drug: Patients will receive steroid pulse therapy
30mg per kg per day for 5 days followed by course of oral prednisolone
Active Comparator: Patients will receive low dose steroids
Drug: Patients will receive low dose steroids
0.6mg per kg perday for 5 days

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie 1 Month Naar 1 Month
Geslachten die in aanmerking komen voor studieAll
Accepteert gezonde vrijwilligersJa
Criteria

Inclusion Criteria:

- Pediatric patients who attending Neurology unit in Assiut University Children Hospital and diagnosed as viral encephalitis.

- Age 1month : 18 year .

- Both sexes.

- Diagnosis of viral encephalitis will be confirmed by clinical picture ,investigations and exclusion of other causes of encephalopathy

Exclusion Criteria:

- Autoimmune encephalitis

- Renal failure (any patient with abnormal renal function tests will be excluded)

- Hepatic failure ( any patient with abnormal liver function tests will be excluded)

- Metabolic disorders (any patient with abnormal level of ammonia and lactate )

Resultaat

Primaire uitkomstmaten

1. Conscious level [5 days]

Glasgow coma scale

Word lid van onze
facebookpagina

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap

  • Werkt in 55 talen
  • Kruidengeneesmiddelen gesteund door de wetenschap
  • Kruidenherkenning door beeld
  • Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
  • Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
  • Zoek medicinale kruiden op hun effecten
  • Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten

Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek

Google Play badgeApp Store badge